ReviewFrontiers in oncology2025
Prevention and management of radiodermatitis in patients with brachytherapy for gynecologic neoplasms summary of the evidence.
Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-enabled precision prediction and proactive management of cutaneous toxicities in cancer immunoradiotherapy (ICI+RT).Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to systematically retrieve, evaluate, and summarize the best evidence regarding the prevention and management of radiation dermatitis in patients undergoing endoluminal radiotherapy for gynecologic neoplasms. The goal is to provide an evidence-based foundation for developing personalized skin management programs. Methods: We conducted a comprehensive search of domestic and international databases, guideline networks, and the websites of relevant professional associations to identify all evidence related to the prevention and management of radiation dermatitis in patients receiving endoluminal radiotherapy for gynecologic neoplasms. The types of literature include guidelines, evidence summaries, systematic reviews, expert consensus, clinical decision-making, and randomized controlled trials. The search period spanned from database inception to September 2024. In addition, we performed hand-searching of key journals and tracked gray literature (including conference abstracts and unpublishe doi: d reports). Results: The review included 14 articles, including 1 clinical decision-making paper, 4 guideline articles, 3 systematic reviews, 3 evidence summary papers, 1 expert consensus document, and 2 randomized controlled trials. We summarized 27 pieces of evidence categorized into 5 themes: assessment and evaluation, health education, general nursing measures, symptom management, and continuity of care. Conclusions: This study consolidates the most effective evidence for managing radiation dermatitis in patients receiving three-dimensional brachytherapy for gynecologic tumors. The findings can serve as a valuable resource for minimizing skin damage and enhancing patients' quality of life. Clinical Trial Registration: http://ebn.nursing.fudan.edu.cn/home, identifier ES20256976.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.